![Heribert Staudinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Heribert Staudinger
Corporate Officer/Principal chez
American Thoracic Society, Inc.
Profil
Heribert Staudinger is a member of the New York Academy of Sciences, American Thoracic Society, and European Respiratory Society.
He was an Independent Non-Executive Director at Niox Group Plc from 2018 to 2019 and was also the Head of Clinical Development at Chiesi Pharmaceuticals, Inc. He holds a doctorate from the University of Hamburg and a graduate degree from Technische Universität Bergakademie Freiberg.
Currently, he holds positions at the New York Academy of Sciences, American Thoracic Society, and European Respiratory Society.
Postes actifs de Heribert Staudinger
| Sociétés | Poste | Début |
|---|---|---|
American Thoracic Society, Inc.
 American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services Profession membership organization for thoracic surgeons. | Corporate Officer/Principal | - |
European Respiratory Society
 European Respiratory Society Pharmaceuticals: MajorHealth Technology Manufactures respiratory medicine | Corporate Officer/Principal | - |
New York Academy of Sciences
 New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Engages in the advancing science, technology and society worldwide services for charity | Corporate Officer/Principal | - |
Anciens postes connus de Heribert Staudinger
| Sociétés | Poste | Fin |
|---|---|---|
| NIOX GROUP PLC | Directeur/Membre du Conseil | 04/02/2019 |
Chiesi Pharmaceuticals, Inc.
 Chiesi Pharmaceuticals, Inc. Aerospace & DefenseElectronic Technology Founded in 2006, Chiesi Pharmaceuticals, Inc. specializes in innovative therapeutic solutions primarily in respiratory health, rare and ultra-rare diseases, neonatology, and specialized care. The private company is based in Rockville, MD. The company operates over 30 commercial subsidiaries and maintains a strong research and development presence through its Parma research center and six other international hubs. Chiesi emphasizes patient-centered care, clinical trial transparency, and supply chain sustainability, engaging suppliers in responsible practices. Its innovation pipeline includes small molecules, biologics, and advanced therapies such as cell therapies, aiming to address unmet medical needs and improve quality of life. | Directeur Technique/Scientifique/R&D | - |
Formation de Heribert Staudinger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
University of Hamburg
 University of Hamburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Engages in the advancing science, technology and society worldwide services for charity | Commercial Services |
American Thoracic Society, Inc.
American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services Profession membership organization for thoracic surgeons. | Commercial Services |
Chiesi Pharmaceuticals, Inc.
Chiesi Pharmaceuticals, Inc. Aerospace & DefenseElectronic Technology Founded in 2006, Chiesi Pharmaceuticals, Inc. specializes in innovative therapeutic solutions primarily in respiratory health, rare and ultra-rare diseases, neonatology, and specialized care. The private company is based in Rockville, MD. The company operates over 30 commercial subsidiaries and maintains a strong research and development presence through its Parma research center and six other international hubs. Chiesi emphasizes patient-centered care, clinical trial transparency, and supply chain sustainability, engaging suppliers in responsible practices. Its innovation pipeline includes small molecules, biologics, and advanced therapies such as cell therapies, aiming to address unmet medical needs and improve quality of life. | Electronic Technology |
European Respiratory Society
European Respiratory Society Pharmaceuticals: MajorHealth Technology Manufactures respiratory medicine | Health Technology |
Technische Universität Bergakademie Freiberg
 Technische Universität Bergakademie Freiberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Niox Group Plc
 Niox Group Plc Medical/Nursing ServicesHealth Services Develops immuno therapies to control immune system responses | Health Services |
